Hallmarks of RET and Co-occuring Genomic Alterations in


Journal

Molecular cancer therapeutics
ISSN: 1538-8514
Titre abrégé: Mol Cancer Ther
Pays: United States
ID NLM: 101132535

Informations de publication

Date de publication:
10 2021
Historique:
received: 14 04 2021
revised: 21 06 2021
accepted: 23 07 2021
pubmed: 9 9 2021
medline: 11 2 2022
entrez: 8 9 2021
Statut: ppublish

Résumé

Activating receptor-tyrosine kinase rearranged during transfection

Identifiants

pubmed: 34493590
pii: 1535-7163.MCT-21-0329
doi: 10.1158/1535-7163.MCT-21-0329
pmc: PMC8492504
mid: NIHMS1731126
doi:

Substances chimiques

Oncogene Proteins, Fusion 0
Protein Kinase Inhibitors 0
Proto-Oncogene Proteins c-ret EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1769-1776

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA242845
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003167
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA180964
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009666
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000371
Pays : United States

Informations de copyright

©2021 The Authors; Published by the American Association for Cancer Research.

Références

Ann Oncol. 2019 Aug 1;30(8):1321-1328
pubmed: 31125062
Ther Adv Med Oncol. 2021 Jun 11;13:17588359211019675
pubmed: 34178121
JCI Insight. 2020 Jun 4;5(11):
pubmed: 32493840
Oncology. 2016;90(6):339-46
pubmed: 27207748
Clin Cancer Res. 2021 Aug 1;27(15):4160-4167
pubmed: 34088726
JCO Precis Oncol. 2021 Jan 11;5:
pubmed: 34036231
Endocr Relat Cancer. 2016 Aug;23(8):665-76
pubmed: 27402614
Cytokine Growth Factor Rev. 2005 Aug-Oct;16(4-5):441-67
pubmed: 15982921
Clin Cancer Res. 2017 Aug 15;23(16):4885-4896
pubmed: 28490466
J Biol Chem. 2015 May 1;290(18):11749-61
pubmed: 25795775
Nat Commun. 2020 Oct 2;11(1):4965
pubmed: 33009371
EMBO J. 2000 Aug 1;19(15):4056-63
pubmed: 10921886
Oncogene. 1989 Dec;4(12):1519-21
pubmed: 2687772
Trends Cancer. 2020 Mar;6(3):181-191
pubmed: 32101722
Br J Cancer. 2009 Jun 2;100(11):1777-83
pubmed: 19401695
Endocr Relat Cancer. 2018 Feb;25(2):T105-T119
pubmed: 28931560
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
J Clin Endocrinol Metab. 2008 Mar;93(3):682-7
pubmed: 18073307
Cancer Lett. 2016 Jul 10;377(1):1-10
pubmed: 27090738
Cancer Discov. 2018 Dec;8(12):1529-1539
pubmed: 30257958
JCO Precis Oncol. 2020 Apr 14;4:
pubmed: 32923911
Ann Oncol. 2021 Feb;32(2):261-268
pubmed: 33161056
Nat Rev Cancer. 2014 Mar;14(3):173-86
pubmed: 24561444
Nature. 1993 Jun 3;363(6428):458-60
pubmed: 8099202
Clin Cancer Res. 2020 Dec 1;26(23):6102-6111
pubmed: 32665298
Oncogene. 2020 Oct;39(41):6493-6510
pubmed: 32884116
Lancet Diabetes Endocrinol. 2021 Aug;9(8):491-501
pubmed: 34118198
J Clin Oncol. 2011 Jul 1;29(19):2660-6
pubmed: 21606412
Endocrinology. 2007 Mar;148(3):936-41
pubmed: 16946010
J Clin Oncol. 2020 Apr 10;38(11):1209-1221
pubmed: 32083997
Oncogene. 2017 Jun 8;36(23):3232-3239
pubmed: 28092668
Ann Oncol. 2021 Jun;32(6):817-819
pubmed: 33617938
Clin Cancer Res. 2017 Apr 15;23(8):1988-1997
pubmed: 27683183
JCO Precis Oncol. 2019;3:
pubmed: 31192313
Trends Cancer. 2021 Jan;7(1):15-28
pubmed: 33008795
Eur J Endocrinol. 2006 Nov;155(5):645-53
pubmed: 17062879
JCO Precis Oncol. 2020 Oct 30;4:
pubmed: 33154983
JCI Insight. 2021 Jan 11;6(1):
pubmed: 33427211
Hum Mol Genet. 1993 Jul;2(7):851-6
pubmed: 8103403
ESMO Open. 2020 Oct;5(5):e000799
pubmed: 33097651
Oncogene. 2013 Apr 18;32(16):2037-47
pubmed: 22751117
F1000Res. 2017 Dec 28;6:2184
pubmed: 29333262
Cancer Treat Rev. 2021 May;96:102179
pubmed: 33798954
Ann Oncol. 2020 Dec;31(12):1725-1733
pubmed: 33007380
Jpn J Clin Oncol. 2020 May 5;50(5):594-601
pubmed: 32083304
Oncologist. 2020 Feb;25(2):94-98
pubmed: 32043794
Oncogene. 2000 Nov 20;19(49):5590-7
pubmed: 11114739
Crit Rev Clin Lab Sci. 2016 Aug;53(4):217-27
pubmed: 26678667
N Engl J Med. 2020 Aug 27;383(9):813-824
pubmed: 32846060
N Engl J Med. 2021 Jun 24;384(25):2382-2393
pubmed: 34161704
Clin Cancer Res. 2019 Oct 1;25(19):5832-5842
pubmed: 31300450
Cell Cycle. 2017 May 3;16(9):813-814
pubmed: 28318386
Nature. 1994 Jan 27;367(6461):375-6
pubmed: 7906866
Cancer Discov. 2020 Apr;10(4):498-505
pubmed: 32094155
J Thorac Oncol. 2020 Apr;15(4):541-549
pubmed: 31988000
Oncol Ther. 2020 Dec;8(2):333-339
pubmed: 32700042
N Engl J Med. 2020 Aug 27;383(9):825-835
pubmed: 32846061
Clin Cancer Res. 2021 Jan 1;27(1):34-42
pubmed: 33082208
Mol Cell Endocrinol. 2008 Mar 12;284(1-2):21-7
pubmed: 18282654
Lancet Oncol. 2021 Jul;22(7):959-969
pubmed: 34118197
Dev Biol. 2007 Jul 15;307(2):290-9
pubmed: 17540362

Auteurs

Jacob J Adashek (JJ)

Department of Internal Medicine, University of South Florida, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
H. Lee Moffitt Cancer Center & Research Institute, Digestive Diseases and Nutrition, University of South Florida, Tampa, Florida.

Aakash P Desai (AP)

Division of Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

Alexander Y Andreev-Drakhlin (AY)

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, Houston, Texas.

Jason Roszik (J)

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, Houston, Texas.

Gilbert J Cote (GJ)

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Vivek Subbiah (V)

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, Houston, Texas. vsubbiah@mdanderson.org.
Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH